Global Paclitaxel Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Paclitaxel Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Paclitaxel Injection size is estimated to be XX million in 2021 from USD 3134.2 million in 2020, with a change of XX% between 2020 and 2021. The global Paclitaxel Injection market size is expected to grow at a CAGR of 10.6% for the next five years.

Market segmentation
Paclitaxel Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    5ml,30mg
    10ml,60mg
    16.7ml,100mg
    25ml,150mg
    50ml,300mg

Market segment by Application can be divided into
    Ovarian Cancer
    Breast Cancer
    Cervical Cancer
    Pancreatic Cancer
    Other

The key market players for global Paclitaxel Injection market are listed below:
    Bristol-Myers Squibb
    Celgene Corporation
    Hospira
    Biological E.
    Taj Accura
    Khandelwal Laboratories
    Luye Pharma
    Beijing Youcare
    Beijing Union
    Haiyao
    Chuntch

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Paclitaxel Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paclitaxel Injection, with price, sales, revenue and global market share of Paclitaxel Injection from 2019 to 2021.
Chapter 3, the Paclitaxel Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Paclitaxel Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Paclitaxel Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Paclitaxel Injection Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Paclitaxel Injection Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 5ml,30mg
        1.2.3 10ml,60mg
        1.2.4 16.7ml,100mg
        1.2.5 25ml,150mg
        1.2.6 50ml,300mg
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Paclitaxel Injection Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Ovarian Cancer
        1.3.3 Breast Cancer
        1.3.4 Cervical Cancer
        1.3.5 Pancreatic Cancer
        1.3.6 Other
    1.4 Global Paclitaxel Injection Market Size & Forecast
        1.4.1 Global Paclitaxel Injection Sales in Value (2016-2026))
        1.4.2 Global Paclitaxel Injection Sales in Volume (2016-2026)
        1.4.3 Global Paclitaxel Injection Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Paclitaxel Injection Production Capacity Analysis
        1.5.1 Global Paclitaxel Injection Total Production Capacity (2016-2026)
        1.5.2 Global Paclitaxel Injection Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Paclitaxel Injection Market Drivers
        1.6.2 Paclitaxel Injection Market Restraints
        1.6.3 Paclitaxel Injection Trends Analysis

2 Manufacturers Profiles
    2.1 Bristol-Myers Squibb
        2.1.1 Bristol-Myers Squibb Details
        2.1.2 Bristol-Myers Squibb Major Business
        2.1.3 Bristol-Myers Squibb Paclitaxel Injection Product and Services
        2.1.4 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Celgene Corporation
        2.2.1 Celgene Corporation Details
        2.2.2 Celgene Corporation Major Business
        2.2.3 Celgene Corporation Paclitaxel Injection Product and Services
        2.2.4 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Hospira
        2.3.1 Hospira Details
        2.3.2 Hospira Major Business
        2.3.3 Hospira Paclitaxel Injection Product and Services
        2.3.4 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Biological E.
        2.4.1 Biological E. Details
        2.4.2 Biological E. Major Business
        2.4.3 Biological E. Paclitaxel Injection Product and Services
        2.4.4 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Taj Accura
        2.5.1 Taj Accura Details
        2.5.2 Taj Accura Major Business
        2.5.3 Taj Accura Paclitaxel Injection Product and Services
        2.5.4 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Khandelwal Laboratories
        2.6.1 Khandelwal Laboratories Details
        2.6.2 Khandelwal Laboratories Major Business
        2.6.3 Khandelwal Laboratories Paclitaxel Injection Product and Services
        2.6.4 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Luye Pharma
        2.7.1 Luye Pharma Details
        2.7.2 Luye Pharma Major Business
        2.7.3 Luye Pharma Paclitaxel Injection Product and Services
        2.7.4 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Beijing Youcare
        2.8.1 Beijing Youcare Details
        2.8.2 Beijing Youcare Major Business
        2.8.3 Beijing Youcare Paclitaxel Injection Product and Services
        2.8.4 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Beijing Union
        2.9.1 Beijing Union Details
        2.9.2 Beijing Union Major Business
        2.9.3 Beijing Union Paclitaxel Injection Product and Services
        2.9.4 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Haiyao
        2.10.1 Haiyao Details
        2.10.2 Haiyao Major Business
        2.10.3 Haiyao Paclitaxel Injection Product and Services
        2.10.4 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Chuntch
        2.11.1 Chuntch Details
        2.11.2 Chuntch Major Business
        2.11.3 Chuntch Paclitaxel Injection Product and Services
        2.11.4 Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Paclitaxel Injection Sales by Manufacturer
    3.1 Global Paclitaxel Injection Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Paclitaxel Injection Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Paclitaxel Injection
    3.4 Market Concentration Rate
        3.4.1 Top 3 Paclitaxel Injection Manufacturer Market Share
        3.4.2 Top 6 Paclitaxel Injection Manufacturer Market Share
    3.5 Global Paclitaxel Injection Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Paclitaxel Injection Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Paclitaxel Injection Market Size by Region
        4.1.1 Global Paclitaxel Injection Sales in Volume by Region (2016-2026)
        4.1.2 Global Paclitaxel Injection Revenue by Region (2016-2026)
    4.2 North America Paclitaxel Injection Revenue (2016-2026)
    4.3 Europe Paclitaxel Injection Revenue (2016-2026)
    4.4 Asia-Pacific Paclitaxel Injection Revenue (2016-2026)
    4.5 South America Paclitaxel Injection Revenue (2016-2026)
    4.6 Middle East and Africa Paclitaxel Injection Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Paclitaxel Injection Sales in Volume by Type (2016-2026)
    5.2 Global Paclitaxel Injection Revenue by Type (2016-2026)
    5.3 Global Paclitaxel Injection Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Paclitaxel Injection Sales in Volume by Application (2016-2026)
    6.2 Global Paclitaxel Injection Revenue by Application (2016-2026)
    6.3 Global Paclitaxel Injection Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Paclitaxel Injection Sales by Type (2016-2026)
    7.2 North America Paclitaxel Injection Sales by Application (2016-2026)
    7.3 North America Paclitaxel Injection Market Size by Country
        7.3.1 North America Paclitaxel Injection Sales in Volume by Country (2016-2026)
        7.3.2 North America Paclitaxel Injection Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Paclitaxel Injection Sales by Type (2016-2026)
    8.2 Europe Paclitaxel Injection Sales by Application (2016-2026)
    8.3 Europe Paclitaxel Injection Market Size by Country
        8.3.1 Europe Paclitaxel Injection Sales in Volume by Country (2016-2026)
        8.3.2 Europe Paclitaxel Injection Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Paclitaxel Injection Sales by Type (2016-2026)
    9.2 Asia-Pacific Paclitaxel Injection Sales by Application (2016-2026)
    9.3 Asia-Pacific Paclitaxel Injection Market Size by Region
        9.3.1 Asia-Pacific Paclitaxel Injection Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Paclitaxel Injection Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Paclitaxel Injection Sales by Type (2016-2026)
    10.2 South America Paclitaxel Injection Sales by Application (2016-2026)
    10.3 South America Paclitaxel Injection Market Size by Country
        10.3.1 South America Paclitaxel Injection Sales in Volume by Country (2016-2026)
        10.3.2 South America Paclitaxel Injection Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Paclitaxel Injection Sales by Type (2016-2026)
    11.2 Middle East & Africa Paclitaxel Injection Sales by Application (2016-2026)
    11.3 Middle East & Africa Paclitaxel Injection Market Size by Country
        11.3.1 Middle East & Africa Paclitaxel Injection Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Paclitaxel Injection Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Paclitaxel Injection Typical Distributors
    12.3 Paclitaxel Injection Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Paclitaxel Injection Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Paclitaxel Injection Revenue by Application, (USD Million), 2021-2026
    Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 4. Bristol-Myers Squibb Major Business
    Table 5. Bristol-Myers Squibb Paclitaxel Injection Product and Services
    Table 6. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 8. Celgene Corporation Major Business
    Table 9. Celgene Corporation Paclitaxel Injection Product and Services
    Table 10. Celgene Corporation Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Hospira Basic Information, Manufacturing Base and Competitors
    Table 12. Hospira Major Business
    Table 13. Hospira Paclitaxel Injection Product and Services
    Table 14. Hospira Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Biological E. Basic Information, Manufacturing Base and Competitors
    Table 16. Biological E. Major Business
    Table 17. Biological E. Paclitaxel Injection Product and Services
    Table 18. Biological E. Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Taj Accura Basic Information, Manufacturing Base and Competitors
    Table 20. Taj Accura Major Business
    Table 21. Taj Accura Paclitaxel Injection Product and Services
    Table 22. Taj Accura Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Khandelwal Laboratories Basic Information, Manufacturing Base and Competitors
    Table 24. Khandelwal Laboratories Major Business
    Table 25. Khandelwal Laboratories Paclitaxel Injection Product and Services
    Table 26. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Luye Pharma Basic Information, Manufacturing Base and Competitors
    Table 28. Luye Pharma Major Business
    Table 29. Luye Pharma Paclitaxel Injection Product and Services
    Table 30. Luye Pharma Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Beijing Youcare Basic Information, Manufacturing Base and Competitors
    Table 32. Beijing Youcare Major Business
    Table 33. Beijing Youcare Paclitaxel Injection Product and Services
    Table 34. Beijing Youcare Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Beijing Union Basic Information, Manufacturing Base and Competitors
    Table 36. Beijing Union Major Business
    Table 37. Beijing Union Paclitaxel Injection Product and Services
    Table 38. Beijing Union Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Haiyao Basic Information, Manufacturing Base and Competitors
    Table 40. Haiyao Major Business
    Table 41. Haiyao Paclitaxel Injection Product and Services
    Table 42. Haiyao Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Chuntch Basic Information, Manufacturing Base and Competitors
    Table 44. Chuntch Major Business
    Table 45. Chuntch Paclitaxel Injection Product and Services
    Table 46. Chuntch Paclitaxel Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Global Paclitaxel Injection Sales by Manufacturer (2019-2021e) & (K Units)
    Table 48. Global Paclitaxel Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 49. Market Position of Manufacturers in Paclitaxel Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 50. Global Paclitaxel Injection Production Capacity by Company, (K Units): 2020 VS 2021
    Table 51. Head Office and Paclitaxel Injection Production Site of Key Manufacturer
    Table 52. Paclitaxel Injection New Entrant and Capacity Expansion Plans
    Table 53. Paclitaxel Injection Mergers & Acquisitions in the Past Five Years
    Table 54. Global Paclitaxel Injection Sales by Region (2016-2021e) & (K Units)
    Table 55. Global Paclitaxel Injection Sales by Region (2021-2026) & (K Units)
    Table 56. Global Paclitaxel Injection Revenue by Region (2016-2021e) & (USD Million)
    Table 57. Global Paclitaxel Injection Revenue by Region (2021-2026) & (USD Million)
    Table 58. Global Paclitaxel Injection Sales by Type (2016-2021e) & (K Units)
    Table 59. Global Paclitaxel Injection Sales by Type (2021-2026) & (K Units)
    Table 60. Global Paclitaxel Injection Revenue by Type (2016-2021e) & (USD Million)
    Table 61. Global Paclitaxel Injection Revenue by Type (2021-2026) & (USD Million)
    Table 62. Global Paclitaxel Injection Price by Type (2016-2021e) & (USD/Unit)
    Table 63. Global Paclitaxel Injection Price by Type (2021-2026) & (USD/Unit)
    Table 64. Global Paclitaxel Injection Sales by Application (2016-2021e) & (K Units)
    Table 65. Global Paclitaxel Injection Sales by Application (2021-2026) & (K Units)
    Table 66. Global Paclitaxel Injection Revenue by Application (2016-2021e) & (USD Million)
    Table 67. Global Paclitaxel Injection Revenue by Application (2021-2026) & (USD Million)
    Table 68. Global Paclitaxel Injection Price by Application (2016-2021e) & (USD/Unit)
    Table 69. Global Paclitaxel Injection Price by Application (2021-2026) & (USD/Unit)
    Table 70. North America Paclitaxel Injection Sales by Country (2016-2021e) & (K Units)
    Table 71. North America Paclitaxel Injection Sales by Country (2021-2026) & (K Units)
    Table 72. North America Paclitaxel Injection Revenue by Country (2016-2021e) & (USD Million)
    Table 73. North America Paclitaxel Injection Revenue by Country (2021-2026) & (USD Million)
    Table 74. North America Paclitaxel Injection Sales by Type (2016-2021e) & (K Units)
    Table 75. North America Paclitaxel Injection Sales by Type (2021-2026) & (K Units)
    Table 76. North America Paclitaxel Injection Sales by Application (2016-2021e) & (K Units)
    Table 77. North America Paclitaxel Injection Sales by Application (2021-2026) & (K Units)
    Table 78. Europe Paclitaxel Injection Sales by Country (2016-2021e) & (K Units)
    Table 79. Europe Paclitaxel Injection Sales by Country (2021-2026) & (K Units)
    Table 80. Europe Paclitaxel Injection Revenue by Country (2016-2021e) & (USD Million)
    Table 81. Europe Paclitaxel Injection Revenue by Country (2021-2026) & (USD Million)
    Table 82. Europe Paclitaxel Injection Sales by Type (2016-2021e) & (K Units)
    Table 83. Europe Paclitaxel Injection Sales by Type (2021-2026) & (K Units)
    Table 84. Europe Paclitaxel Injection Sales by Application (2016-2021e) & (K Units)
    Table 85. Europe Paclitaxel Injection Sales by Application (2021-2026) & (K Units)
    Table 86. Asia-Pacific Paclitaxel Injection Sales by Region (2016-2021e) & (K Units)
    Table 87. Asia-Pacific Paclitaxel Injection Sales by Region (2021-2026) & (K Units)
    Table 88. Asia-Pacific Paclitaxel Injection Revenue by Region (2016-2021e) & (USD Million)
    Table 89. Asia-Pacific Paclitaxel Injection Revenue by Region (2021-2026) & (USD Million)
    Table 90. Asia-Pacific Paclitaxel Injection Sales by Type (2016-2021e) & (K Units)
    Table 91. Asia-Pacific Paclitaxel Injection Sales by Type (2021-2026) & (K Units)
    Table 92. Asia-Pacific Paclitaxel Injection Sales by Application (2016-2021e) & (K Units)
    Table 93. Asia-Pacific Paclitaxel Injection Sales by Application (2021-2026) & (K Units)
    Table 94. South America Paclitaxel Injection Sales by Country (2016-2021e) & (K Units)
    Table 95. South America Paclitaxel Injection Sales by Country (2021-2026) & (K Units)
    Table 96. South America Paclitaxel Injection Revenue by Country (2016-2021e) & (USD Million)
    Table 97. South America Paclitaxel Injection Revenue by Country (2021-2026) & (USD Million)
    Table 98. South America Paclitaxel Injection Sales by Type (2016-2021e) & (K Units)
    Table 99. South America Paclitaxel Injection Sales by Type (2021-2026) & (K Units)
    Table 100. South America Paclitaxel Injection Sales by Application (2016-2021e) & (K Units)
    Table 101. South America Paclitaxel Injection Sales by Application (2021-2026) & (K Units)
    Table 102. Middle East & Africa Paclitaxel Injection Sales by Country (2016-2021e) & (K Units)
    Table 103. Middle East & Africa Paclitaxel Injection Sales by Country (2021-2026) & (K Units)
    Table 104. Middle East & Africa Paclitaxel Injection Revenue by Country (2016-2021e) & (USD Million)
    Table 105. Middle East & Africa Paclitaxel Injection Revenue by Country (2021-2026) & (USD Million)
    Table 106. Middle East & Africa Paclitaxel Injection Sales by Type (2016-2021e) & (K Units)
    Table 107. Middle East & Africa Paclitaxel Injection Sales by Type (2021-2026) & (K Units)
    Table 108. Middle East & Africa Paclitaxel Injection Sales by Application (2016-2021e) & (K Units)
    Table 109. Middle East & Africa Paclitaxel Injection Sales by Application (2021-2026) & (K Units)
    Table 110. Direct Channel Pros & Cons
    Table 111. Indirect Channel Pros & Cons
    Table 112. Paclitaxel Injection Typical Distributors
    Table 113. Paclitaxel Injection Typical Customers
List of Figures
    Figure 1. Paclitaxel Injection Picture
    Figure 2. Global Paclitaxel Injection Sales Market Share by Type in 2020
    Figure 3. 5ml,30mg
    Figure 4. 10ml,60mg
    Figure 5. 16.7ml,100mg
    Figure 6. 25ml,150mg
    Figure 7. 50ml,300mg
    Figure 8. Global Paclitaxel Injection Sales Market Share by Application in 2020
    Figure 9. Ovarian Cancer
    Figure 10. Breast Cancer
    Figure 11. Cervical Cancer
    Figure 12. Pancreatic Cancer
    Figure 13. Other
    Figure 14. Global Paclitaxel Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 15. Global Paclitaxel Injection Market Size and Forecast (2016-2026) & (USD Million)
    Figure 16. Global Paclitaxel Injection Sales (2016-2026) & (K Units)
    Figure 17. Global Paclitaxel Injection Price by Type (2016-2026) & (USD/Unit)
    Figure 18. Global Paclitaxel Injection Production Capacity (2016-2026) & (K Units)
    Figure 19. Global Paclitaxel Injection Production Capacity by Geographic Region: 2020 VS 2021
    Figure 20. Paclitaxel Injection Market Drivers
    Figure 21. Paclitaxel Injection Market Restraints
    Figure 22. Paclitaxel Injection Market Trends
    Figure 23. Global Paclitaxel Injection Sales Market Share by Manufacturer in 2020
    Figure 24. Global Paclitaxel Injection Revenue Market Share by Manufacturer in 2020
    Figure 25. Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 26. Top 3 Paclitaxel Injection Manufacturer (Revenue) Market Share in 2020
    Figure 27. Top 6 Paclitaxel Injection Manufacturer (Revenue) Market Share in 2020
    Figure 28. Global Paclitaxel Injection Sales Market Share by Region (2016-2026)
    Figure 29. Global Paclitaxel Injection Revenue Market Share by Region (2016-2026)
    Figure 30. North America Paclitaxel Injection Revenue (2016-2026) & (USD Million)
    Figure 31. Europe Paclitaxel Injection Revenue (2016-2026) & (USD Million)
    Figure 32. Asia-Pacific Paclitaxel Injection Revenue (2016-2026) & (USD Million)
    Figure 33. South America Paclitaxel Injection Revenue (2016-2026) & (USD Million)
    Figure 34. Middle East & Africa Paclitaxel Injection Revenue (2016-2026) & (USD Million)
    Figure 35. Global Paclitaxel Injection Sales Market Share by Type (2016-2026)
    Figure 36. Global Paclitaxel Injection Revenue Market Share by Type (2016-2026)
    Figure 37. Global Paclitaxel Injection Price by Type (2016-2026) & (USD/Unit)
    Figure 38. Global Paclitaxel Injection Sales Market Share by Application (2016-2026)
    Figure 39. Global Paclitaxel Injection Revenue Market Share by Application (2016-2026)
    Figure 40. Global Paclitaxel Injection Price by Application (2016-2026) & (USD/Unit)
    Figure 41. North America Paclitaxel Injection Sales Market Share by Type (2016-2026)
    Figure 42. North America Paclitaxel Injection Sales Market Share by Application (2016-2026)
    Figure 43. North America Paclitaxel Injection Sales Market Share by Country (2016-2026)
    Figure 44. North America Paclitaxel Injection Revenue Market Share by Country (2016-2026)
    Figure 45. United States Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Canada Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Mexico Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Europe Paclitaxel Injection Sales Market Share by Type (2016-2026)
    Figure 49. Europe Paclitaxel Injection Sales Market Share by Application (2016-2026)
    Figure 50. Europe Paclitaxel Injection Sales Market Share by Country (2016-2026)
    Figure 51. Europe Paclitaxel Injection Revenue Market Share by Country (2016-2026)
    Figure 52. Germany Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. France Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. United Kingdom Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Russia Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Italy Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Asia-Pacific Paclitaxel Injection Sales Market Share by Region (2016-2026)
    Figure 58. Asia-Pacific Paclitaxel Injection Sales Market Share by Application (2016-2026)
    Figure 59. Asia-Pacific Paclitaxel Injection Sales Market Share by Region (2016-2026)
    Figure 60. Asia-Pacific Paclitaxel Injection Revenue Market Share by Region (2016-2026)
    Figure 61. China Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Japan Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Korea Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. India Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Southeast Asia Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Australia Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. South America Paclitaxel Injection Sales Market Share by Type (2016-2026)
    Figure 68. South America Paclitaxel Injection Sales Market Share by Application (2016-2026)
    Figure 69. South America Paclitaxel Injection Sales Market Share by Country (2016-2026)
    Figure 70. South America Paclitaxel Injection Revenue Market Share by Country (2016-2026)
    Figure 71. Brazil Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Argentina Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Middle East & Africa Paclitaxel Injection Sales Market Share by Type (2016-2026)
    Figure 74. Middle East & Africa Paclitaxel Injection Sales Market Share by Application (2016-2026)
    Figure 75. Middle East & Africa Paclitaxel Injection Sales Market Share by Country (2016-2026)
    Figure 76. Middle East & Africa Paclitaxel Injection Revenue Market Share by Country (2016-2026)
    Figure 77. Turkey Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Egypt Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Saudi Arabia Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. South Africa Paclitaxel Injection Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Sales Channel: Direct Channel vs Indirect Channel
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Related Reports

Global Paclitaxel Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Paclitaxel Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Paclitaxel Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Paclitaxel Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Paclitaxel Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Global Paclitaxel Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Paclitaxel Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Paclitaxel Injection market size was valued at USD 3482 million in 2023 and is forecast to a readjusted size of USD 7058.9 million by 2030 with a CAGR of 10.6% during review period.

Global Paclitaxel Injection Supply, Demand and Key Producers, 2024-2030

Global Paclitaxel Injection Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Paclitaxel Injection market size is expected to reach $ 7058.9 million by 2030, rising at a market growth of 10.6% CAGR during the forecast period (2024-2030).

Product Tags

paclitaxel injection

Paclitaxel Injection (Albumin-bound)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>